Cycling 10,000 kms for 1,000 Patient Navigational Journals
Support my ride for patient journals: Patient Journals better equip and empower patients, to respond survive an unexpected cancer diagnosis - they bridge the knowledge gap
Support my ride for patient journals: Patient Journals better equip and empower patients, to respond survive an unexpected cancer diagnosis - they bridge the knowledge gap
Bridging Science and Patients: A Revolution in Cancer Treatment to unlock the power of translational genomics to empower cancer patients.
Embracing a Metabolic Perspective: A New Era of Patient-Centered, Innovative Cancer Care, Transforming Treatment, and Empowering Individuals. Steve Holmes "Survival became an Unexpected [...]
Exploring the possibilities beyond a cholangiocarcinoma diagnosis, embracing critical thinking, collaboration, increasing patient empowerment
Unleashing your Power, One Question at a Time: Be Open, Be Willing, Be Consistent, and take control of your cancer challenge
Boehringer Ingelheim is studying BI 907828, an investigational MDM2-p53 antagonist, for advanced biliary tract or pancreatic cancer.